The developing heart and congenital heart defects: A make or break situation

Clinical Genetics

Volumn 63, Issue 4, 2003, Pages 252-261

  Bruneau, Benoit G ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Congenital heart defects; Embryo; Gene expression; Heart; Morphogenesis

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 10; HELIX LOOP HELIX PROTEIN; HOMEODOMAIN PROTEIN; HYALURONIC ACID DERIVATIVE; MADS DOMAIN PROTEIN; REGULATOR PROTEIN; SERUM RESPONSE FACTOR; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA2; WNT PROTEIN;

CELL DIFFERENTIATION; CHROMOSOME 22Q; CHROMOSOME DELETION; CONGENITAL HEART MALFORMATION; EMBRYO SEGMENTATION; GENE DELETION; HEART ATRIUM; HEART ATRIUM SEPTUM; HEART DEVELOPMENT; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION SYSTEM; HEART VALVE; HEART VENTRICLE; HEART VENTRICLE SEPTUM; HETEROTAXY SYNDROME; HUMAN; MAMMAL; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; HEART; HEART DEFECTS, CONGENITAL; HUMANS; MICE; MODELS, ANIMAL; MORPHOGENESIS; TRANSCRIPTION FACTORS;

MAMMALIA;

EID: 0042632702     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2003.00066.x     Document Type: Review

References (74)

1. Harvey RP. NK-2 homeobox genes and heart development. Dev Biol 1996: 178: 203-216.
2. Tanaka M, Chen Z, Bartunkova M et al. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 1999: 126: 1269-1280.
3. Lyons I, Parsons LM, Hartley L et al. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 1995: 9: 1654-1666.
4. Tanaka M, Schinke M, Liao HS et al. Nkx2.5 and Nkx2.6, homologs of drosophila tinman, are required for development of the pharynx. Mol Cell Biol 2001: 21: 4391-4398.
5. Fu Y, Yan W, Mohun TJ et al. Vertebrate tinman homologues XNkx2-3 and XNkx2-5 are required for heart formation in a functionally redundant manner. Development 1998: 125: 4439-4449.
6. Bruneau BG. Transcriptional regulation of vertebrate cardiac morphogenesis. Circ Res 2002: 90: 509-519.
7. Arsenian S, Weinhold B, Oelgeschlager M et al. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J 1998: 17: 6289-6299.
8. Wang D, Chang PS, Wang Z et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 2001: 105: 851-862.
9. Schultheiss TM, Burch JB, Lassar AB. A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev 1997: 11: 451-462.
10. Zhang H, Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996: 122: 2977-2986.
11. Reifers F, Walsh EC, Leger S et al. Induction and differentiation of the zebrafish heart requires fibroblast growth factor 8 (fgf8/acerebellar). Development 2000: 127: 225-235.
12. Alsan BH, Schultheiss TM. Regulation of avian cardiogenesis by Fgf8 signaling. Development 2002: 129: 1935-1943.
13. Meyers EN, Lewandoski M, Martin GR. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 1998: 18: 136-141.
14. Marvin MJ, Di Rocco G, Gardiner A et al. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev 2001: 15: 316-327.
15. Schneider VA, Mercola M. Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev 2001: 15: 304-315.
16. Tzahor E, Lassar AB. Wnt signals from the neural tube block ectopic cardiogenesis. Genes Dev 2001: 15: 255-260.
17. Lickert H, Kutsch S, Kanzler B et al. Formation of multiple hearts in mice following deletion of beta-catenin in the embryonic endoderm. Dev Cell 2002: 3: 171-181.
18. Pandur P, Lasche M, Eisenberg LM et al. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 2002: 418: 636-641.
19. Christoffels VM, Habets PE, Franco D et al. Chamber formation and morphogenesis in the developing mammalian heart. Dev Biol 2000: 223: 266-278.
20. Srivastava D, Thomas T, Lin Q et al. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat Genet 1997: 16: 154-160.
21. Yamagishi H, Yamagishi C, Nakagawa O et al. The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation. Dev Biol 2001: 239: 190-203.
22. Lin Q, Schwarz J, Bucana C et al. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 1997: 276: 1404-1407.
23. Bruneau BG, Nemer G, Schmitt JP et al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 2001: 106: 709-721.
24. Gottlieb PD, Pierce SA, Sims RJ et al. Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis. Nat Genet 2002: 31: 25-32.
25. Bao Z-Z, Bruneau BG, Seidman JG et al. Irx4 regulates chamber-specific gene expression in the developing heart. Science 1999: 283: 1161-1164.
26. Bruneau BG, Bao ZZ, Fatkin D et al. Cardiomyopathy in Irx4-deficient mice is preceded by abnormal ventricular gene expression. Mol Cell Biol 2001: 21: 1730-1736.
27. Habets PE, Moorman AF. Clout DE et al. Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. Genes Dev 2002: 16: 1234-1246.
28. Kelly RG, Brown NA, Buckingham ME. The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev Cell 2001: 1: 435-440.
29. Waldo KL, Kumiski DH, Wallis KT et al. Conotruncal myocardium arises from a secondary heart field. Development 2001: 128: 3179-3188.
30. Vitelli F, Taddei I, Morishima M et al. A genetic link between Tbx1 and fibroblast growth factor signaling. Development 2002: 129: 4605-4611.
31. Bruneau BG. Mouse models of cardiac chamber formation and congenital heart disease. Trends Genet 2002: 18: S15-S20.
32. Brown CB, Boyer AS, Runyan RB et al. Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science 1999: 283: 2080-2082.
33. Nakajima Y, Yamagishi T, Hokari S et al. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat Rec 2000: 258: 119-127.
34. Gaussin V, Van de Putte T, Mishina Y et al. Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc Natl Acad Sci USA 2002: 99: 2878-2883.
35. Walsh EC, Stainier DY. UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish. Science 2001: 293: 1670-1673.
36. Ranger AM, Grusby MJ, Hodge MR et al. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 1998: 392: 186-190.
37. de la Pompa JL, Timmerman LA, Takimoto H et al. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 1998: 392: 182-186.
38. Camenisch TD, Schroeder JA, Bradley J et al. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med 2002: 8: 850-855.
39. Camenisch TD, Spicer AP, Brehm-Gibson T et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 2000: 106: 349-360.
40. Kumai M, Nishii K, Nakamura K et al. Loss of connexin45 causes a cushion defect in early cardiogenesis. Development 2000: 127: 3501-3512.
41. Chen B, Bronson RT, Klaman LD et al. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet 2000: 24: 296-299.
42. Bartram U, Molin DG, Wisse LJ et al. Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-beta (2)-knockout mice. Circulation, 2001: 103: 2745-2752.
43. Ya J, Schilham MW, de Boer PA et al. Sox4-deficiency syndrome in mice is an animal model for common trunk. Circ Res 1998: 83: 986-994.
44. Pennisi DJ, Rentschler S, Gourdie RG et al. Induction and patterning of the cardiac conduction system. Int J Dev Biol 2002: 46: 765-775.
45. Gourdie RG, Wei Y, Kim D et al. Endothelin-induced conversion of embryonic heart muscle cells into impulse-conducting Purkinje fibers. Proc Natl Acad Sci USA 1998: 95: 6815-6818.
46. Rentschler S, Vaidya DM, Tamaddon H et al. Visualization and functional characterization of the developing murine-cardiac conduction system. Development 2001: 128: 1785-1792.
47. Rentschler S, Zander J, Meyers K et al. Neuregulin-1 promotes formation of the murine cardiac conduction system. Proc Natl Acad Sci USA 2002: 99: 10464-10469.
48. Shioi T, Kang PM, Douglas PS et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 2000: 19: 2537-2548.
49. Crackower MA, Oudit GY, Kozieradzki I et al. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 2002: 110: 737-749.
50. Shin CH, Liu ZP, Passier R et al. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 2002: 110: 725-735.
51. Chen F, Kook H, Milewski R et al. Hop is an unusual homeobox gene that modulates cardiac development. Cell 2002: 110: 713-723.
52. Benson DW, Sharkey A, Fatkin D et al. Reduced penetrance, variable expressivity, and genetic heterogeneity of familial atrial septal defects. Circulation 1998: 97: 2043-2048.
53. Schott J-J, Benson DW, Basson CT et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998: 281: 108-111.
54. Benson DW, Silberbach GM, Kavanaugh-McHugh A et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 1999: 104: 1567-1573.
55. Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with tetralogy of fallot. Circulation 2001: 104: 2565-2568.
56. Capdevila J, Vogan KJ, Tabin CJ et al. Mechanisms of left-right determination in vertebrates. Cell 2000: 101: 9-21.
57. Bamford RN, Roessler E, Burdine RD et al. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet 2000: 26: 365-369.
58. Goldmuntz E, Bamford R, Karkera JD et al. CFC1 mutations in patients with transposition of the great arteries and double-outlet right ventricle. Am J Hum Genet 2002: 70: 776-780.
59. Schlange T, Schnipkoweit I, Andree B et al. Chick CFC controls Lefty1 expression in the embryonic midline and nodal expression in the lateral plate. Dev Biol 2001: 234: 376-389.
60. Scambler PJ. The 22q11 deletion syndromes. Hum Mol Genet 2000: 9: 2421-2426.
61. Epstein JA. Developing models of DiGeorge syndrome. Trends Genet 2001: 17: S13-S17.
62. Lindsay EA, Botta A, Jurecic V et al. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 1999: 401: 379-383.
63. Lindsay EA, Vitelli F, Su H et al. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 2001: 410: 97-101.
64. Merscher S, Funke B, Epstein JA et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 2001: 104: 619-629.
65. Jerome LA, Papaioannou VE. Di George syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 2001: 27: 286-291.
66. Kochilas L, Merscher-Gomez S, Lu MM et al. The role of neural crest during cardiac development in a mouse model of DiGeorge syndrome. Dev Biol 2002: 251: 157-166.
67. Biben C, Weber R, Kesteven S et al. Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ Res 2000: 87: 888-895.
68. Taddei I, Morishima M, Huynh T et al. Genetic factors are major determinants of phenotypic variability in a mouse model of the DiGeorge/del22q11 syndromes. Proc Natl Acad Sci USA 2001: 98: 11428-11431.
69. McCright B, Lozier J, Gridley T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002: 129: 1075-1082.
70. Tevosian SG, Deconinck AE, Tanaka M et al. FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell 2000: 101: 729-739.
71. Svensson EC, Huggins GS, Lin H et al. A syndrome of tricuspid atresia in mice with a targeted mutation of the gene encoding Fog-2. Nat Genet 2000: 25: 353-356.
72. Donovan J, Kordylewska A, Jan Y et al. Tetralogy of fallot and other congenital heart defects in hey2 mutant mice. Curr Biol 2002: 12: 1605.
73. Gessler M, Knobeloch K, Helisch A et al. Mouse gridlock. No aortic coarctation or deficiency, but fatal cardiac defects in Hey2 -/- mice. Curr Biol 2002: 12: 1601.
74. Bruneau BG, Logan M, Davis N et al. Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev Biol 1999: 211: 100-108.